Articles related to ANXIETY
Challenge Case Report: Tic Disorder in an Adult
Test your clinical knowledge on JB, a right-handed, 35-year-old patient with a history of generalized anxiety disorder, who came into the clinic to be evaluated and managed for atypical movements that started in adolescence. JB frequently exhibits quick shoulder shrugs, abrupt head movements to the right, and throat clearing during the neurologic examination. Examination results for the cerebellum, motor, sensory, and reflexes are unremarkable.
Neurology September 19th 2022
Clinical Effectiveness of Intravenous Racemic Ketamine Infusions in a Large Community Sample of Patients with Treatment-Resistant Depression, Suicidal Ideation, and Generalized Anxiety Symptoms: A Retrospective Chart Review
SI, sadness, and anxiety symptoms could all be effectively treated with ketamine. The high rates of response and remission in population samples of TRD were comparable to those for interventional therapies. Racemic ketamine infusion as the main treatment for SI requires randomized controlled trials and comparative efficacy studies with other therapies.
Psychiatry September 19th 2022
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection with Risk of Post–COVID-19 Conditions
This cohort study discovered that depression, anxiety, perceived stress, loneliness, and worry about COVID-19 were prospectively associated with a 1.3- to 1.5-fold increased risk of self-reported post-COVID-19 conditions, as well as an increased risk of daily life impairment related to post-COVID-19 conditions.
Psychiatry September 12th 2022
Thyroid Hormone Use in Mood Disorders: Revisiting the Evidence
The author concludes that “careful use of T3 and L-T4 can be critical mood-stabilizingoptions, especially for depressive illness that has not responded to first-line therapies,and can provide an alternative to other augmentation strategies such as atypicalantipsychotics, lithium, or esketamine/ketamine.”
Psychiatry August 16th 2022
Vitamin B6 Supplementation May Reduce Anxiety, Depression
In this study enrolling 478 young adults, of which 265 self-reported anxiety and 146 self-reported depression, high-dose vitamin B6 supplementation raised brain GABA levelsand reduced self-reported anxiety.
Psychiatry August 16th 2022
Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial
Treatment resistance affects nearly half of all young people experiencing moderate-to-severe anxiety. In this 12-week open-label trial, patients received add-on CBD after noclinical improvement on therapy with CBT and/or antidepressant medication. There wasa more than 40% reduction in mean OASIS scores and no serious or unexpectedadverse events.
Pediatrics August 16th 2022